SGLT2 and SGLT1 inhibitors suppress the activities of the RVLM neurons in newborn Wistar rats-Reference-Cited by-同舟云学术

SGLT2 and SGLT1 inhibitors suppress the activities of the RVLM neurons in newborn Wistar rats

Published:2023-09-15 Issue:1 Volume:47 Page:46-54
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Oshima Naoki,Onimaru Hiroshi,Yamashiro Aoi,Goto Hiroyasu,Tanoue Keiko,Fukunaga Tsugumi,Sato Hiroki,Uto Asuka,Matsubara Hidehito,Imakiire Toshihiko,Kumagai Hiroo

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

https://www.nature.com/articles/s41440-023-01417-5.pdf

Reference26 articles.

1. Ghezzi C, Loo DD, Wright EM. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2. Diabetologia. 2018;61:2087–97.

2. Aguilar-Gallardo JS, Correa A, Contreras JP. Cardio-renal benefits of sodium-glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence. Eur Heart J Cardiovasc Pharmacother. 2022;8:311–21.

3. Erdogan MA, Yusuf D, Christy J, Solmaz V, Erdogan A, Taskiran E, et al. Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy. BMC Neurol. 2018;18:81.

4. Takeda K, Ono H, Ishikawa K, Ohno T, Kumagai J, Ochiai H, et al. Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats. BMJ Open Diabetes Res Care. 2021;9:e002104.

5. Al Hamed FA, Elewa H. Potential therapeutic effects of sodium glucose-linked cotransporter 2 inhibitors in stroke. Clin Ther. 2020;42:e242–9.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art;American Journal of Cardiovascular Drugs;2024-08-24

2. Respiratory modulation of sympathetic transduction to blood pressure in health and type 2 diabetes;The Journal of Physiology;2024-07-29

3. The relationship between SGLT2 and systemic blood pressure regulation;Hypertension Research;2024-05-23

4. A comprehensive meta-analysis on the association of SGLT2is and GLP-1RAs with vascular diseases, digestive diseases and fractures;Acta Diabetologica;2024-05-07

5. Inhibiting SGLTs diminishes sympathetic output by reducing rostral ventrolateral medulla (RVLM) neuron activity;Hypertension Research;2023-11-22